Taxing questions for corporates

Now, I am no tax expert, but Merck’s current dispute with the IRS over the off-shoring of a part of its patent portfolio looks to have many serious implications for companies that try to get creative with IP and tax. What is clear is that a number…

Get unlimited access to all IAM content